# Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts

> **NCT04649541** · PHASE1 · COMPLETED · sponsor: **MicuRx** · enrollment: 69 (actual)

## Conditions studied

- Safety

## Interventions

- **DRUG:** MRX-8
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04649541
- **Lead sponsor:** MicuRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-29
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2023-08-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04649541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04649541, "Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04649541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*